Announce Date | 03/13/2025 |
EPS Normalized Actual | $-0.3551 (Beat by $0.1049) |
EPS GAAP Actual | $-0.3551 (Beat by $0.1049) |
Revenue Actual | $0.047004B |
Revenue Surprise | Beat by $47.004M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.16788 |
EPS GAAP Estimate | $-0.16788 |
Revenue Estimate | $0.109541891B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.23 | 0.37 | 2.95066 | 5.50739 | 1 |
Dec 2028 | 2.49 | 0.63 | 2.23932 | 2.62851 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.36 | -0.36 | 0.047004B | -50.55% | 47M |
FQ3 2024 (Sep 2024) | -0.38 | -0.38 | 0.081441B | 15.66% | 81.44M |
FQ2 2024 (Jun 2024) | -0.66 | -0.66 | 0.066561B | 32.22% | 66.56M |
FQ1 2024 (Mar 2024) | -0.58 | -0.58 | 0.072634B | 97.04% | 72.63M |
FQ4 2003 (Oct 2003) | 0 | 0 | 0B | NAN% | 0M |
FQ1 2004 (Jan 2004) | 0 | 0 | 0B | NAN% | 0M |
FQ4 2004 (Oct 2004) | 0 | 0 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | -0.64 | -0.64 | 0.070764B | 100% | 70.76M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.16788
Consensus Revenue Estimates
0.109541891B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 1 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 1 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 1 |
FQ4 2026 (Oct 2026) | -0.14522 | -- | -0.16278 | -0.12749 | 1 |
FQ3 2026 (Jul 2026) | -0.1296 | -- | -0.14527 | -0.11378 | 1 |
FQ2 2026 (Jun 2026) | 0.11739 | -- | 0.09133829 | 0.14732 | 0 |
FQ1 2026 (Mar 2026) | 0.08208 | -- | 0.06386444 | 0.10301 | 0 |
FQ4 2025 (Oct 2025) | -0.11671 | -208.46 | -0.13082 | -0.10246 | 2 |
FQ3 2025 (Jul 2025) | -0.15464 | -145.73 | -0.17334 | -0.13576 | 2 |
FQ2 2025 (Jun 2025) | -0.16788 | -293.14 | -0.21068 | -0.13062 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.17B | -- | 0.16B | 0.17B | 1 |
FQ2 2027 (Jun 2027) | 0.16B | -- | 0.16B | 0.17B | 1 |
FQ1 2027 (Mar 2027) | 0.16B | -- | 0.15B | 0.17B | 1 |
FQ4 2026 (Oct 2026) | 0.24B | -- | 0.21B | 0.26B | 2 |
FQ3 2026 (Jul 2026) | 0.2B | -- | 0.18B | 0.22B | 2 |
FQ2 2026 (Jun 2026) | 0.2B | -- | 0.16B | 0.24B | 1 |
FQ1 2026 (Mar 2026) | 0.19B | -- | 0.16B | 0.23B | 1 |
FQ4 2025 (Oct 2025) | 0.14B | 65.51 | 0.12B | 0.15B | 1 |
FQ3 2025 (Jul 2025) | 0.13B | 34.95 | 0.11B | 0.14B | 1 |
FQ2 2025 (Jun 2025) | 0.11B | 39.24 | 0.09B | 0.13B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
5
EPS # of in-lines
3
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.36 | -0.36 | 100% | |
FQ3 2024 (Sep 2024) | -0.38 | -0.38 | 100% | |
FQ2 2024 (Jun 2024) | -0.66 | -0.66 | 100% | |
FQ1 2024 (Mar 2024) | -0.58 | -0.58 | 100% | |
FQ4 2003 (Oct 2003) | 0 | 0 | NAN% | |
FQ1 2004 (Jan 2004) | 0 | 0 | NAN% | |
FQ4 2004 (Oct 2004) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | -0.64 | -0.64 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.05B | $47M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.08B | $81.44M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.07B | $66.56M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.07B | $72.63M | 100% |
FQ4 2003 (Oct 2003) | $0B | $0B | $0M | NAN% |
FQ1 2004 (Jan 2004) | $0B | $0B | $0M | NAN% |
FQ4 2004 (Oct 2004) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0.07B | $70.76M | 100% |